News
AVCNF
0.265
+6.29%
0.016
Weekly Report: what happened at AVCNF last week (0415-0419)?
Weekly Report · 6d ago
Avicanna Secures Funding to Fuel Growth
TipRanks · 04/18 21:38
AVICANNA ANNOUNCES CLOSING OF NON-BROKERED PRIVATE PLACEMENT
Reuters · 04/18 21:00
Weekly Report: what happened at AVCNF last week (0408-0412)?
Weekly Report · 04/15 11:20
Avicanna’s Gel Shows Promise for Pain Relief
TipRanks · 04/10 13:07
Avicanna Announces Completion of Topical Gel Observational Real-World Evidence Study
Avicanna Inc. Announces completion of its observational real-world evidence study using RHO Phyto branded cannabigerol transdermal gel on patients with musculoskeletal pain and inflammation. The company is a biopharmaceutical company focused on the development of plant-derived cannabinoid-based products.
Barchart · 04/10 07:37
Weekly Report: what happened at AVCNF last week (0401-0405)?
Weekly Report · 04/08 11:25
Avicanna reports FY results
Seeking Alpha · 04/02 14:09
Cannabinoid-Based Products Maker Sees Triple-Digit Growth In 2023 Gross Profit, Revenue Surges 314% YoY
Avicanna Inc. Reported its year-end 2023 results and audited financial statements on Tuesday. The Canadian company reported CA$16.8 million in total revenue, up by 314% year-over-year. Avicanna attributed the surge in revenue to the acquisition of Medical Cannabis by Shoppers.
Benzinga · 04/02 13:18
Avicanna Inc. Celebrates Soaring 2023 Profits
TipRanks · 04/02 12:18
AVICANNA REPORTS FULL YEAR 2023 AUDITED FINANCIAL RESULTS
Reuters · 04/02 11:30
Weekly Report: what happened at AVCNF last week (0325-0329)?
Weekly Report · 04/01 11:23
Avicanna Releases New CBD Formulation in Canada
TipRanks · 03/27 12:49
Avicanna Announces the Canadian Launch of 10% CBD (THC Free) Proprietary Formulation
Barchart · 03/27 07:02
Avicanna Announces Full Year 2023 Earnings Call
TipRanks · 03/26 12:17
Avicanna To Hold Full Year 2023 Earnings Conference Call
Avicanna Inc. Is a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based products. Avicanna will hold a conference call to discuss the Company's Full Year 2023 financial results on March 26, 2024.
Barchart · 03/26 06:30
Weekly Report: what happened at AVCNF last week (0318-0322)?
Weekly Report · 03/25 11:26
Weekly Report: what happened at AVCNF last week (0311-0315)?
Weekly Report · 03/18 11:24
Weekly Report: what happened at AVCNF last week (0304-0308)?
Weekly Report · 03/11 11:20
Weekly Report: what happened at AVCNF last week (0226-0301)?
Weekly Report · 03/04 11:23
More
Webull provides a variety of real-time AVCNF stock news. You can receive the latest news about Avicanna through multiple platforms. This information may help you make smarter investment decisions.
About AVCNF
Avicanna Inc. is a Canada-based biopharmaceutical company. The Company is focused on the research, development, and commercialization of plant-derived cannabinoid-based products for the global consumer, medical, and pharmaceutical market segments. In addition to its developing pharmaceutical pipeline, it has product lines, including Pura H&W and RHO Phyto. Pura H&W is a line of cannabidiol (CBD) consumer derma-cosmetic products. RHO Phyto is a line of medical cannabis products containing varying ratios of CBD and tetrahydrocannabinol (THC). The Company's subsidiary includes Sativa Nativa S.A.S. and Santa Marta Golden Hemp S.A.S.